AREVA logo


The future

As a result of the ICM’s innovative design, research laboratories and a treatment center are located on the same site. The synergies created between researchers and doctors make the ICM the largest center of its kind in the world. Patients are able to benefit from the most recent discoveries without having to wait.

Today, more than one person in eight suffers from a brain or spinal chord illness (paraplegia, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, etc.), and this poses a serious public health problem.

A program to find new therapies

The AREVA Corporate Foundation has signed on for three years with the ICM for a research program that uses the neuronavigation equipment it funded.

The program’s objective is to gain a better understanding of brain malfunction in dystonia, a disease characterized by involuntary muscle contractions responsible for abnormal movements.

The project will study communication anomalies between neurons in two regions of the brain, the cortex and the cerebellum, in order to influence abnormal rhythms with external stimulation and return them to normal.

The only currently existing treatment is drug-based and has limited efficacy, or major surgery for severe forms of the disease.

A long-term partnership

The AREVA Corporate Foundation began working in 2008 to help create this 22,000 m2 building at the Pitié-Salpêtrière Hospital, which was inaugurated at the end of 2010.

It renewed its commitment in 2012 by funding the acquisition of a neuronavigation system for the neuroimaging platform. This equipment combines anatomical images with cerebral function to reconstitute the brain three-dimensionally in a virtual space specific to each patient.